![](/img/cover-not-exists.png)
Efficacy and safety of bispecific T-cell engager (BiTE) antibody blinatumomab for the treatment of relapsed/refractory acute lymphoblastic leukemia and non-Hodgkin’s lymphoma: a systemic review and meta-analysis
Yu, Jian, Wang, Wen, Huang, HeVolume:
24
Language:
english
Journal:
Hematology
DOI:
10.1080/16078454.2018.1549802
Date:
January, 2019
File:
PDF, 2.67 MB
english, 2019